18 Apr 2018
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/pfenex-and-nt-pharma-enter-into-a-development-and-license-agreement-for-pfenexs-pf708-therapeutic-equivalent-candidate-to-forteo-300632434.html
04 Apr 2018
// PATENT LITIGATION
09 Jan 2018
// Zachary Brennan RAPS
http://raps.org/Regulatory-Focus/News/2018/01/09/29156/FDA-Denies-Amneal-Petition-Seeking-to-Block-Generic-Versions-of-Osteoporosis-Treatment/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
09 Nov 2017
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/new-data-on-forteo-teriparatide-rdna-origin-injection-showed-reduced-risk-for-new-vertebral-and-clinical-fractures-in-postmenopausal-women-with-severe-osteoporosis-300553474.html
21 Aug 2017
// PR NEWSWIRE
http://www.prnewswire.com/news-releases/the-indian-peptides-and-heparin-market-worth-8830-million-and-1702-million-usd-by-2022-respectively-641199763.html
05 May 2017
// EMA
https://www.pharmacompass.com/pdf/news/gedeon-richter-plc-terrosa-teriparatide-receives-approval-in-europe-1494071806.pdf
LOOKING FOR A SUPPLIER?